Bioprinting, 9780190943547
Hardcover
Print organs, heal bodies: a new frontier in medicine awaits.

Bioprinting

to make ourselves anew

$111.81

  • Hardcover

    320 pages

  • Release Date

    11 August 2021

Check Delivery Options

Summary

Bioprinting: To Make Ourselves Anew

Of the 121,000 people on donor lists in the U.S., over 100,000 need kidney transplants, and thousands die each year while waiting. Bioprinting aspires to build healthy kidney tissue from a patient’s own cells and transplant this to boost failing kidneys without fear of rejection…

As the 21st century dawned, a handful of inspired scientists tried to use 3D printing to create living human tissue. Their vision was to restore the health of peo…

Book Details

ISBN-13:9780190943547
ISBN-10:0190943548
Author:Kenneth Douglas
Publisher:Oxford University Press Inc
Imprint:Oxford University Press Inc
Format:Hardcover
Number of Pages:320
Release Date:11 August 2021
Weight:680g
Dimensions:157mm x 236mm x 23mm
What They're Saying

Critics Review

This book is superb! Ken Douglas has an amazing talent for weaving in and out of complicated topics and making them easy to understand. He writes in an engaging, conversational style, taking the reader inside the laboratory and introducing the personalities behind the science. Using down-to-earth examples and descriptive language, he makes complex scientific concepts come to life for the general public. He has done a magnificent job outlining what has been accomplished to date and the challenges that remain. Well done, Ken Douglas! * Anthony Atala, MD, G. Link Professor and Director, Wake Forest Institute for Regenerative Medicine *The amount and breadth of basic research in bioprinting is astounding. It is a huge mix of approaches with cell biology, tissue engineering, and printing methods that start from scratch with basic cells and create living tissues. Douglas takes us through this maze step by step and makes historical and clinical sense of the direction and pace of this research. * Charles “Chuck” W. Hull, Inventor of Stereolithography (a.k.a. 3D Printing); Co-Founder, Executive Vice President, and Chief Technical Officer, 3D Systems *In this book, Ken Douglas tells how bioprinting first emerged at the turn of the 21st century, the enormous potential it offers for transforming the field of organ transplantation, and the real challenges that must be overcome in order for it to succeed and have an impact on the future of health care. It is a story of creativity, drive, perseverance, and passion, and it is told by recounting the personal stories of many of the key scientists who have led the chase. * From the Foreword by Donald E. Ingber, MD, Director, Wyss Institute for Biologically Inspired Engineering, Harvard University *Magic happens when we combine a 3D printer with tissue engineering and regenerative medicine. Add materials science, biotechnology, and medical technology, and the result is an explosion of innovation in 3D engineered tissues. Through a storytelling method, this fine book provides readers with insights into how bioprinting has changed tissue engineering and regenerative medicine and how it can change the way we approach human diseases in the future. * Dong-Woo Cho, Nam-Go Chair Professor, Department of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), South Korea; Director, Center for Rapid Prototyping-Based 3D Tissue/Organ Printing *

About The Author

Kenneth Douglas

Kenneth Douglas is a research faculty member in the Department of Physics at the University of Colorado Boulder. He earned a BA in mathematics and an MS in physics at the University of Chicago and a PhD in physics at the University of Colorado Boulder. Douglas’ laboratory created the strategy of employing the surface layers of bacterial extremophiles as biomolecular masks to generate ordered nanostructured materials. His first book was DNANanoscience: From Prebiotic Origins to Emerging Nanotechnology (2017).

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.